Heart Failure Pharmacology
Sort by:
ACC 2022 Conference Coverage
ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendations for HFrEF and HFmrEF Treatment
FEATURING
Paul Heidenreich
- 18,678 views
- April 21, 2022
- 58
ACC 2023 Conference Coverage
ACC 2023: SGLT2i Use - Dos and Don'ts
FEATURING
Anastasia Armbruster
- 17,315 views
- March 31, 2023
- 95
MUSC Cardiology
Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Trials
FEATURING
Robert Mentz
- 8,701 views
- September 14, 2023
- 57
AHA 2022 Conference Coverage
AHA 2022: Torsemide Comparison With Furosemide for Management of Heart Failure - TRANSFORM-HF Trial
FEATURING
Robert Mentz
- 7,443 views
- November 21, 2022
- 27
VuMedi Webinars
Heart Failure: Latest Treatment Advances
Faculty: Thomas Heywood, Daniel Burkhoff, John R. Teerlink, Akshay Desai, Peter Pang
- 5,142 views
- June 22, 2017
- 9
Scripps Health
HFpEF or Amyloidosis? The Right Therapies for Right Patients
FEATURING
Michelle Kittleson
- 5,071 views
- May 6, 2022
- 34
ACC 2022 Conference Coverage
Hot Topics in Heart Failure ACC.22
FEATURING
Nasrien Ibrahim
- 3,491 views
- April 22, 2022
- 33
13th Orange County Symposium for Cardiovascular Disease Prevention
SGLT2 inhibitors and GLP-1 agonists: Why Are They Important and Which Do I Choose?
FEATURING
Yehuda Handelsman
- 3,402 views
- January 27, 2022
- 14
Top Ten Topics in Clinical Cardiology 2023
Medical Management of Diastolic Dysfunction: Does The Emperor Finally Have Clothes?
FEATURING
Sean Pinney
- 2,901 views
- November 8, 2023
- 24
University of California, Irvine (UCI) Health 14th Annual Orange County Symposium for Cardiovascular Disease Prevention
Prevention of Heart Failure: New 2022 Guidelines
FEATURING
Andy Lee
- 2,528 views
- November 15, 2022
- 6
Texas Cardiovascular Innovations Conference 2021
New Heart Failure Treatment Recommendations
FEATURING
Albert Hicks
- 2,272 views
- March 3, 2022
- 14
Clyde Yancy
ACC/AHA/HFSA Update on New Pharmacological Therapy for Heart Failure
- 2,179 views
- October 12, 2016
- 9
Houston Shock Symposium
Why Is Epinephrine Not the Drug of Choice for Cardiogenic Shock
FEATURING
Esther Vorovich
- 2,113 views
- March 10, 2023
- 10
15th Annual Orange County Symposium for Cardiovascular Disease Prevention
HFpEF vs. HfrEF State of the Art Prevention and Treatment
FEATURING
Andy Lee
- 2,036 views
- November 24, 2023
- 8
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Recognizing and Treating HFpEF: How Helpful Are MRAs, ARNi and SGLT2 Inhibitors for Treating Patients? What Have We Learned From The PARADIGM and PARAGON Trials?
FEATURING
Barry Greenberg
- 2,010 views
- February 5, 2021
- 22